TPA for stroke: the story of a controversial drug
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
New York
Oxford University Press
2011
|
| Schlagworte: | |
| Online-Zugang: | FAW01 FAW02 Volltext |
| Beschreibung: | Includes bibliographical references and index Code stroke on Market street -- Clot-buster : the natural history -- Dead or alive -- Brain-O -- The brain doctors cometh : slowly -- What emergency? -- Money and brains -- Deer in the headlights -- Call 911, 112, 15 ... even 999 -- Persistence of a most controversial drug -- Through the looking glass -- Post-script Without warning stroke can paralyze, blind, or kill. Some victims recover, but many do not and may even suffer another disabling or fatal attack. The drug known as tPA can drastically reduce the long-term disability associated with stroke, but despite its near-miraculous capabilities and the growing support of most neurologists, it has been slow to win acceptance as the standard of care in emergency departments nationwide. tPA for Stroke chronicles how this remarkable drug came to be tested in stroke victims, its early years in development by the pharmaceutical giant Genentech, and its eventua |
| Beschreibung: | 1 Online-Ressource (xiv, 191 pages) |
| ISBN: | 0195393929 0199780943 9780195393927 9780199780945 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV043107386 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 151126s2011 |||| o||u| ||||||eng d | ||
| 020 | |a 0195393929 |9 0-19-539392-9 | ||
| 020 | |a 0199780943 |c electronic bk. |9 0-19-978094-3 | ||
| 020 | |a 9780195393927 |9 978-0-19-539392-7 | ||
| 020 | |a 9780199780945 |c electronic bk. |9 978-0-19-978094-5 | ||
| 035 | |a (OCoLC)729244831 | ||
| 035 | |a (DE-599)BVBBV043107386 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-1046 |a DE-1047 | ||
| 082 | 0 | |a 616.8/106 |2 22 | |
| 100 | 1 | |a Zivin, Justin A. |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a TPA for stroke |b the story of a controversial drug |c Justin A. Zivin, John Galbraith Simmons |
| 264 | 1 | |a New York |b Oxford University Press |c 2011 | |
| 300 | |a 1 Online-Ressource (xiv, 191 pages) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 500 | |a Includes bibliographical references and index | ||
| 500 | |a Code stroke on Market street -- Clot-buster : the natural history -- Dead or alive -- Brain-O -- The brain doctors cometh : slowly -- What emergency? -- Money and brains -- Deer in the headlights -- Call 911, 112, 15 ... even 999 -- Persistence of a most controversial drug -- Through the looking glass -- Post-script | ||
| 500 | |a Without warning stroke can paralyze, blind, or kill. Some victims recover, but many do not and may even suffer another disabling or fatal attack. The drug known as tPA can drastically reduce the long-term disability associated with stroke, but despite its near-miraculous capabilities and the growing support of most neurologists, it has been slow to win acceptance as the standard of care in emergency departments nationwide. tPA for Stroke chronicles how this remarkable drug came to be tested in stroke victims, its early years in development by the pharmaceutical giant Genentech, and its eventua | ||
| 650 | 4 | |a Stroke / drug therapy | |
| 650 | 4 | |a Stroke / History | |
| 650 | 4 | |a Fibrinolytic Agents / therapeutic use | |
| 650 | 4 | |a Tissue Plasminogen Activator / History | |
| 650 | 4 | |a Tissue Plasminogen Activator / therapeutic use | |
| 650 | 4 | |a Fibrinolytic Agents / Therapeutic use | |
| 650 | 4 | |a Medicine | |
| 650 | 7 | |a MEDICAL / Neurology |2 bisacsh | |
| 650 | 7 | |a Cerebrovascular disease / Chemotherapy |2 fast | |
| 650 | 7 | |a Tissue plasminogen activator / Therapeutic use |2 fast | |
| 650 | 4 | |a Geschichte | |
| 650 | 4 | |a Medizin | |
| 650 | 4 | |a Cerebrovascular disease |x Chemotherapy |x History | |
| 650 | 4 | |a Tissue plasminogen activator |x Therapeutic use |x History | |
| 700 | 1 | |a Simmons, John |e Sonstige |4 oth | |
| 856 | 4 | 0 | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=368817 |x Aggregator |3 Volltext |
| 912 | |a ZDB-4-EBA | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-028531577 | ||
| 966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=368817 |l FAW01 |p ZDB-4-EBA |q FAW_PDA_EBA |x Aggregator |3 Volltext | |
| 966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=368817 |l FAW02 |p ZDB-4-EBA |q FAW_PDA_EBA |x Aggregator |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804175523360800768 |
|---|---|
| any_adam_object | |
| author | Zivin, Justin A. |
| author_facet | Zivin, Justin A. |
| author_role | aut |
| author_sort | Zivin, Justin A. |
| author_variant | j a z ja jaz |
| building | Verbundindex |
| bvnumber | BV043107386 |
| collection | ZDB-4-EBA |
| ctrlnum | (OCoLC)729244831 (DE-599)BVBBV043107386 |
| dewey-full | 616.8/106 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.8/106 |
| dewey-search | 616.8/106 |
| dewey-sort | 3616.8 3106 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03201nmm a2200565zc 4500</leader><controlfield tag="001">BV043107386</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">151126s2011 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0195393929</subfield><subfield code="9">0-19-539392-9</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0199780943</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">0-19-978094-3</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780195393927</subfield><subfield code="9">978-0-19-539392-7</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780199780945</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">978-0-19-978094-5</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)729244831</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV043107386</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-1046</subfield><subfield code="a">DE-1047</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.8/106</subfield><subfield code="2">22</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Zivin, Justin A.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">TPA for stroke</subfield><subfield code="b">the story of a controversial drug</subfield><subfield code="c">Justin A. Zivin, John Galbraith Simmons</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York</subfield><subfield code="b">Oxford University Press</subfield><subfield code="c">2011</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (xiv, 191 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Code stroke on Market street -- Clot-buster : the natural history -- Dead or alive -- Brain-O -- The brain doctors cometh : slowly -- What emergency? -- Money and brains -- Deer in the headlights -- Call 911, 112, 15 ... even 999 -- Persistence of a most controversial drug -- Through the looking glass -- Post-script</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Without warning stroke can paralyze, blind, or kill. Some victims recover, but many do not and may even suffer another disabling or fatal attack. The drug known as tPA can drastically reduce the long-term disability associated with stroke, but despite its near-miraculous capabilities and the growing support of most neurologists, it has been slow to win acceptance as the standard of care in emergency departments nationwide. tPA for Stroke chronicles how this remarkable drug came to be tested in stroke victims, its early years in development by the pharmaceutical giant Genentech, and its eventua</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Stroke / drug therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Stroke / History</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Fibrinolytic Agents / therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Tissue Plasminogen Activator / History</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Tissue Plasminogen Activator / therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Fibrinolytic Agents / Therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medicine</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Neurology</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cerebrovascular disease / Chemotherapy</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Tissue plasminogen activator / Therapeutic use</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Geschichte</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cerebrovascular disease</subfield><subfield code="x">Chemotherapy</subfield><subfield code="x">History</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Tissue plasminogen activator</subfield><subfield code="x">Therapeutic use</subfield><subfield code="x">History</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Simmons, John</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=368817</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-028531577</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=368817</subfield><subfield code="l">FAW01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FAW_PDA_EBA</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=368817</subfield><subfield code="l">FAW02</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FAW_PDA_EBA</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| id | DE-604.BV043107386 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T07:17:38Z |
| institution | BVB |
| isbn | 0195393929 0199780943 9780195393927 9780199780945 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-028531577 |
| oclc_num | 729244831 |
| open_access_boolean | |
| owner | DE-1046 DE-1047 |
| owner_facet | DE-1046 DE-1047 |
| physical | 1 Online-Ressource (xiv, 191 pages) |
| psigel | ZDB-4-EBA ZDB-4-EBA FAW_PDA_EBA |
| publishDate | 2011 |
| publishDateSearch | 2011 |
| publishDateSort | 2011 |
| publisher | Oxford University Press |
| record_format | marc |
| spelling | Zivin, Justin A. Verfasser aut TPA for stroke the story of a controversial drug Justin A. Zivin, John Galbraith Simmons New York Oxford University Press 2011 1 Online-Ressource (xiv, 191 pages) txt rdacontent c rdamedia cr rdacarrier Includes bibliographical references and index Code stroke on Market street -- Clot-buster : the natural history -- Dead or alive -- Brain-O -- The brain doctors cometh : slowly -- What emergency? -- Money and brains -- Deer in the headlights -- Call 911, 112, 15 ... even 999 -- Persistence of a most controversial drug -- Through the looking glass -- Post-script Without warning stroke can paralyze, blind, or kill. Some victims recover, but many do not and may even suffer another disabling or fatal attack. The drug known as tPA can drastically reduce the long-term disability associated with stroke, but despite its near-miraculous capabilities and the growing support of most neurologists, it has been slow to win acceptance as the standard of care in emergency departments nationwide. tPA for Stroke chronicles how this remarkable drug came to be tested in stroke victims, its early years in development by the pharmaceutical giant Genentech, and its eventua Stroke / drug therapy Stroke / History Fibrinolytic Agents / therapeutic use Tissue Plasminogen Activator / History Tissue Plasminogen Activator / therapeutic use Fibrinolytic Agents / Therapeutic use Medicine MEDICAL / Neurology bisacsh Cerebrovascular disease / Chemotherapy fast Tissue plasminogen activator / Therapeutic use fast Geschichte Medizin Cerebrovascular disease Chemotherapy History Tissue plasminogen activator Therapeutic use History Simmons, John Sonstige oth http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=368817 Aggregator Volltext |
| spellingShingle | Zivin, Justin A. TPA for stroke the story of a controversial drug Stroke / drug therapy Stroke / History Fibrinolytic Agents / therapeutic use Tissue Plasminogen Activator / History Tissue Plasminogen Activator / therapeutic use Fibrinolytic Agents / Therapeutic use Medicine MEDICAL / Neurology bisacsh Cerebrovascular disease / Chemotherapy fast Tissue plasminogen activator / Therapeutic use fast Geschichte Medizin Cerebrovascular disease Chemotherapy History Tissue plasminogen activator Therapeutic use History |
| title | TPA for stroke the story of a controversial drug |
| title_auth | TPA for stroke the story of a controversial drug |
| title_exact_search | TPA for stroke the story of a controversial drug |
| title_full | TPA for stroke the story of a controversial drug Justin A. Zivin, John Galbraith Simmons |
| title_fullStr | TPA for stroke the story of a controversial drug Justin A. Zivin, John Galbraith Simmons |
| title_full_unstemmed | TPA for stroke the story of a controversial drug Justin A. Zivin, John Galbraith Simmons |
| title_short | TPA for stroke |
| title_sort | tpa for stroke the story of a controversial drug |
| title_sub | the story of a controversial drug |
| topic | Stroke / drug therapy Stroke / History Fibrinolytic Agents / therapeutic use Tissue Plasminogen Activator / History Tissue Plasminogen Activator / therapeutic use Fibrinolytic Agents / Therapeutic use Medicine MEDICAL / Neurology bisacsh Cerebrovascular disease / Chemotherapy fast Tissue plasminogen activator / Therapeutic use fast Geschichte Medizin Cerebrovascular disease Chemotherapy History Tissue plasminogen activator Therapeutic use History |
| topic_facet | Stroke / drug therapy Stroke / History Fibrinolytic Agents / therapeutic use Tissue Plasminogen Activator / History Tissue Plasminogen Activator / therapeutic use Fibrinolytic Agents / Therapeutic use Medicine MEDICAL / Neurology Cerebrovascular disease / Chemotherapy Tissue plasminogen activator / Therapeutic use Geschichte Medizin Cerebrovascular disease Chemotherapy History Tissue plasminogen activator Therapeutic use History |
| url | http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=368817 |
| work_keys_str_mv | AT zivinjustina tpaforstrokethestoryofacontroversialdrug AT simmonsjohn tpaforstrokethestoryofacontroversialdrug |